- Previous Close
0.0030 - Open
0.0000 - Bid --
- Ask 0.0040 x --
- Day's Range
0.0030 - 0.0030 - 52 Week Range
0.0020 - 0.0100 - Volume
0 - Avg. Volume
247,250 - Market Cap (intraday)
-- - Beta (5Y Monthly) 1.03
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 30, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.
www.scu.com.sg--
Full Time Employees
June 30
Fiscal Year Ends
--
Sector
--
Industry
Recent News: BP8.XA
View MorePerformance Overview: BP8.XA
Trailing total returns as of 10/1/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BP8.XA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BP8.XA
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-99.30%
Return on Equity (ttm)
--
Revenue (ttm)
109.97k
Net Income Avi to Common (ttm)
-1.6M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
134.82k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-935.87k